Audio By Vocalize
ISAAA AfriCenter director Dr Margaret Karembu. [Nanjinia Wamuswa, Standard]
Africa’s biotechnology and biosafety information which had been scattered across multiple agency websites, gazette notices and regulatory documents, making it difficult for users to access and interpret, has been centralised.
This had in the past denied traders, regulators and researchers access to information on issues such as approval decisions for biotech products, including crops and animals, for cultivation, import, export and transit.
The fragmented biosafety regulatory requirements and application procedures led to delays in decision-making, compliance ambiguities, and uncertainty for regulators, researchers, and traders operating across borders.
